NCT04846933
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +14 more
- Locations
-
- Turku University Hospital Turku, Finland
Clinical trial condition
High Grade Serous Carcinoma
Explore clinical trials studying High Grade Serous Carcinoma. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
High Grade Serous Carcinoma trial results
NCT05080556
- Conditions
- Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
- Locations
-
- University College London Hospitals London, United Kingdom
NCT03462342
- Conditions
- High Grade Serous Carcinoma
- Locations
-
- Johns Hopkins University School of Medicine Baltimore, Maryland, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States
NCT05490407
- Conditions
- Adnexal Diseases, Chemotherapy Effect, Endocrine Gland Neoplasms, +16 more
- Locations
-
- Department of Gynecology, Division of Gynecology and Obstetrics, Ljubljana University Medical Center Ljubljana, Slovenia
- Institute of Pharmacology and Experimental Toxicology, Faculty of Medicine, University of Ljubljana. Ljubljana, Slovenia
NCT03593681
- Conditions
- Abdominal Neoplasms, Adnexal Diseases, Adnexal Mass, +26 more
- Locations
-
- Scripps Clinic Medical Group San Diego, California, United States
- Kaiser Permanente San Francisco Medical Center San Francisco, California, United States
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
Active, Not Recruiting
Combination of Olaparib and Navitoclax in Women with HGSC and TNBC
NCT05358639
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +20 more
- Locations
-
- Sunnybrook Research Institute/Odette Cancer Centre Toronto, Ontario, Canada
- Princess Margaret Cancer Centre Toronto, Ontario, Canada
- CHUM Montreal, Quebec, Canada